Cargando…

Characterization of a rat model of bortezomib‐induced painful neuropathy

BACKGROUND AND PURPOSE: Bortezomib (Velcade®) is a breakthrough treatment for multiple myeloma, significantly improving patient survival. However, its use is limited by painful neuropathy often resulting in dose reduction/cessation of first‐line treatment due to lack of treatment. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Duggett, Natalie A, Flatters, Sarah J L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727311/
https://www.ncbi.nlm.nih.gov/pubmed/28972650
http://dx.doi.org/10.1111/bph.14063